KR20000052842A - Compositions for reducing body odors and excess moisture - Google Patents

Abstract

PURPOSE: An odor and moisture absorbing composition is provided for reducing body odor and excess moisture on occluded skin sites. CONSTITUTION: An odor and moisture absorbing composition comprises: a) 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; b) a powder carrier; and c) 5% to 60%, by weight of the composition, of a highly effective moisture absorber; and wherein the composition is safe for use on skin.

Description

Composition for reducing body odor and excess moisture {COMPOSITIONS FOR REDUCING BODY ODORS AND EXCESS MOISTURE}

Background of the Invention

Body odors are mostly derived from malodors from fatty acids and microbial sources on the skin. Human skin is inherently filled with various skin secretions (sweat and sebum secreted by exocrine and apocrine glands), skin cell debris, breakdown products of the skin and numerous microorganisms that are nourished by the microorganisms themselves. This unpleasant body odor mainly consists of organic molecules having different structures and different functional groups such as amines, acids, alcohols, aldehydes, ketones, phenolic, polycyclic, indole, aromatic, polyaromatic and the like. They may also consist of sulfur-containing functional groups such as thiols, mercaptans, sulfides and / or disulfide groups.

There have been numerous attempts to suppress or absorb body odors. Attempts have been made to remove the moisture / moisture environment necessary for their growth and growth from the microorganisms responsible for body odor. This effort involves the use of powders and / or antiperspirants. Conventional body powders and powder-based compositions have limited absorption. Restrictive agents are not always preferred as body deodorant products because, when used throughout the body, they may conflict with the body's heat regulation methods by inhibiting sweating through the action of astringent salts. In addition, the salts cause irritation in many users, especially when applied to sensitive areas such as the pelvic area.

Other deodorant compositions for inhibiting / eliminating body odor associated with skin secretions, as described in the literature in the chemical and cosmetic fields, include emulsion sticks or suspension sticks, aerosols, roll-ons, pads, pump sprays and even It even includes a soap bar. These known deodorants have been attempted to remove odors through various means. For example, US Pat. No. 5,525,331 (Betts, published June 11, 1996) discloses compositions that inhibit the growth of microorganisms in body secretions. Deodorants also include antimicrobial compounds that help destroy bacteria present on the skin / inhibit the amount of bacteria, thus minimizing odor generated through the bacterial metabolic activity of skin secretions.

Zeolite is a known odorant. However, the known activated carbon absorbent and the solid absorbent lose their function when wet. Therefore, when wetted by body fluid or transported in an aqueous solution, the odorant is not preferable because it loses the desired odor characteristics. Moreover, zeolites can cause a feeling of "roughness" if too much is deposited on the skin.

In addition to the above attempts to suppress and / or absorb body odors, there have been numerous attempts to mask body odors by using other odors or perfumes. However, perfumes are often unsuitable for completely hiding body odors and they cause irritation to users when used alone to suppress odors.

Therefore, there is a need for improved malodor and moisture absorbent compositions that are essentially free of irritating ingredients such as perfumes or astringent limiting agents and are safe and effective for systemic use. More specifically, there is a need for convenient compositions that can absorb a wide range of body odor and excess moisture that are not completely overwhelmed by the aforementioned means, and remain on the skin.

Odorless uncomplexed cyclodextrins; It has been found that by using a composition comprising a high efficiency moisture absorption component and a powder carrier and remaining on the skin, such improved body odor and moisture inhibition can be provided safely throughout the body. A characteristic advantage of the present invention is that it can provide convenient and non-irritating odor and moisture protection when used in occluded skin areas such as highly sensitive pelvic areas, vulva, panty-site, bra-line, and skin folds. Discovered ability. Moreover, it has been found that the above-described advantages may be provided in powder carriers, which in some cases also provide skin supplemental benefits such as protection and / or hydration to the user.

These and other objects of the present invention will be readily apparent from the detailed description that follows.

All percentages, ratios, and parts in the specification, examples, and claims are by weight unless otherwise indicated. As used herein, the term "g" means gram. As used herein, the term "ml" means milliliters.

Summary of the Invention

The present invention relates to an odorless powder absorbent composition which, based on the weight of the composition, contains from about 0.1% to about 25% uncomplexed cyclodextrin and powder carrier and is safe for use on human skin. The present invention also relates to powdered malodor and moisture absorbent compositions which additionally comprise from about 5% to about 60% high efficiency moisture absorbent, by weight of the composition. The compositions of the present invention may also contain additional odor inhibitors selected from the group consisting of: zeolites, activated carbons, sodium bicarbonates, antibacterial and limiting agents.

The present invention also relates to the use of said composition to reduce excess moisture on body odor and occluded skin.

Detailed description of the invention

The present invention relates to fragrance free dry powder odorants and optionally moisture absorbent compositions. The invention also relates to the use of said powder composition to reduce excess moisture from body odor and occluded skin, wherein the powder composition is applied to the occluded skin. The composition may be applied directly to the occluded skin with a nebulizer, applied by hand, shaken from a bottle or canister, or applied via a dry wipe.

The composition of the present invention comprises a dry ingredient, preferably having a particle size of about 1 micron to about 100 microns: more preferably about 1 micron to about 60 microns: most preferably about 1 micron to about 20 microns. . Particle size as used herein refers to particles of the largest dimension of the particles and ultimate (or primary) particles.

As used herein, the term "occluded skin" includes pelvic zone, panty-zone and bra-line; And a body part covered with underwear, such as an intertriginous area where skin-fold or inter-skin contact continues.

As used herein, the term "body fluid" includes sweat secreted by the exocrine glands, sweat secreted by the apocrine glands, sebum, significant water accumulation from loss of water through the skin, vaginal discharge, urine, and mixtures thereof.

As used herein, the term "excessive moisture" refers to an undesirable or filthy degree of fluid deposited on human skin.

The term "body odor" as used herein means an odor that occurs as a result of the body's natural actions. Such odors include, but are not limited to, odors produced by microorganisms on human skin (ie, bacterial degradation of skin secretions), urine or vaginal discharges, and mixtures thereof.

The term "full body" refers to the entire outer surface of the skin of a human or mammal.

The term "vaginal odor" specifically relates to body odor emitted from the pelvic region of women, especially the vagina and panty region.

Detailed descriptions of the essential and optional ingredients of the present invention are given below.

Cyclodextrin

The term "cyclodextrin" as used herein refers to any known cyclodextrin, for example an unsubstituted cyclodextrin containing 6 to 12 glucose units, in particular alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin. And / or derivatives thereof and / or mixtures thereof.

As used herein, the term "non-complexed cyclodextrin" means that the cavity in the cyclodextrin in the composition of the present invention is essentially unfilled prior to application so that the cyclodextrin can absorb various odor molecules when the composition is applied to the skin. It means being in a state.

Preferred cyclodextrins used in the present invention are alpha-cyclodextrins, beta-cyclodextrins, gamma-cyclodextrins and / or derivatives thereof. More preferred are beta cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta cyclodextrin, methylated alpha-cyclodextrin or methylated beta-cyclodextrin. Most preferred is beta cyclodextrin.

Preference is also given to using mixtures of cyclodextrins. This mixture absorbs body odors more broadly by complexing with a wider range of odor molecules with a wider range of molecular sizes. The level of cyclodextrin is about 0.1% to about 25% by weight of the composition, preferably about 1% to about 20%, more preferably about 2% to about 15%, most preferably about 3% to about 10 % to be.

Complexation between cyclodextrins and odor molecules occurs rapidly when wetted with body fluids. Cyclodextrins are convenient for the user because they are on dry skin and do not fill their cavities with the odors of other surroundings (otherwise less effective for absorbing body odors). More particularly, upon dissolution of cyclodextrin by body fluids, the sequestered cavities can form inclusion complexes with body odor molecules. Thus, ultimately, the usefulness of dissolved uncomplexed cyclodextrins is essential for efficient and effective odor removal performance.

Cyclodextrins with small particle sizes help to provide higher surface utility of cyclodextrins for adsorption and are therefore preferred. Particle size as used herein refers to particles of maximum dimension and ultimate (or primary) particles. Small particle cyclodextrins of the present invention are those having a particle size of about 12 microns or less, preferably about 10 microns or less, more preferably about 5 microns or less. More complete descriptions of cyclodextrins, derivatives of cyclodextrins and particle sizes of cyclodextrins useful in the present invention can be found in US Pat. No. 5,429,628, Trinh et al., Filed Jul. 4, 1995, which is hereby incorporated by reference in its entirety. It is included in the literature.

Powder carrier

Cyclodextrins and other optional ingredients useful in the present invention should be dispersed in a pharmaceutically acceptable powder carrier for convenient and uniform application and disbursement on the skin. As used herein, the term "pharmaceutically acceptable" means a powder suitable for topical use on the skin that is free of excessive toxicity, irritation, allergic reactions, and the like. The powder carrier also helps to prevent any dissolved cyclodextrin from being washed away from desirable skin contact. Powder carriers useful in the present invention include conventionally known powders that are safe for use for human skin. Such powders include corn starch (dermal starch), talc, unstarred, oat starch, tapioca starch, microcrystalline cellulose (e.g. ), Aluminum starch octenyl succinate (trade name Dry Flo of National Starch & Chemical Co.) Pure, Dry Flo XT and / or Dry Flo PC), kaolin and mixtures thereof, but is not limited to these. Corn starch is preferred.

The powder carrier of the invention consists of about 10% to about 95%, preferably about 15% to about 80%, more preferably about 25% to about 50%, relative to the composition.

High efficiency moisture absorbent

High efficiency moisture absorbents may optionally be included in the present invention to assist in reducing excess moisture on occluded skin. High efficiency moisture absorbers also increase the flowability (flow force without cake formation due to moisture) of the compositions of the present invention. As used herein, the term "high efficiency moisture absorber" refers to silica (silicon dioxide), silicates or carbonates, wherein the silicates and carbonates are silicates or carbonates and alkali metals (IA), alkaline earth metals (IIA) or It is formed by reaction with a transition metal. Preferred high efficiency moisture absorbers are calcium silicate, amorphous silica, calcium carbonate, magnesium carbonate or zinc carbonate and mixtures thereof. Specific examples of some of the silicates and carbonates useful in the present invention are described in detail in the Encyclopedia of Chemistry (Van Nostrand Reinhold, 1984, 4th edition, pages 155, 169, 556, and 849), incorporated herein by reference. Included.

Because of the safety risks associated with crystalline silica, synthetic versions of high efficiency moisture absorbers are preferred, especially for silica and silicates. In the process, a synthetic version of the compound is formed by controlled chemical reactions rather than a natural, mined version of the compound, which requires more purification.

Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker, Clark and Daniels. Examples of synthetic calcium silicates useful in the present invention include the trade name Hubersorb sold by JM Huber. 250 or Hubersorb There is 600.

The high efficiency moisture absorbent of the present invention preferably comprises about 5% to about 60%, more preferably about 10% to about 50%, most preferably about 20% to about 40% by weight of the total composition. .

Odor Control Supplements

The compositions of the present invention may optionally contain zeolites, carbon odor-inhibitors, sodium bicarbonates, antibacterial and / or limiter components for additional odor suppression.

As used herein, "zeolite" refers to a non-fibrous zeolite. When included in the present invention, the zeolite may be present from about 0.1% to about 25%, preferably from about 1% to about 15% by weight of the composition. Zeolites useful in the present invention are described in detail in US Pat. No. 5,429,628 (Trinh et al., Published July 4, 1995), which is hereby incorporated by reference in its entirety.

Carbon malodor-inhibitors described in US Pat. No. 5,429,628 may be used in the present invention at levels of about 0.1% to about 25% by weight of the composition.

It is known in the art that sodium bicarbonate is used as the sorbent. Examples of sodium bicarbonate and their use as armpit deodorants are described in US Pat. No. 4,382,079 (Marschner, published May 3, 1983), which is incorporated by reference in its entirety. When included in the present invention, sodium bicarbonate may be present from about 0.1% to about 50% by weight of the composition.

The antimicrobial agent of the present invention is selected from the group consisting of antibacterial agents, antifungal agents and mixtures thereof. Antibacterial agents help to kill or inhibit the amount of bacteria and / or fungi present on the skin. Preferred antibacterial agents are zinc phenolsulfonate, zinc oxide, triclosan, the trade name Zelec of DuPont. AM, zinc ricinoleate, zinc undecylenate and mixtures thereof. More preferred antibacterial agents are zinc phenolsulfonate, zinc oxide and triclosan. Triclosan is sold under the tradename Irgasan DP-300 by Ciba-Geigy. Examples of antimicrobials useful in the present invention are described in the Cosmetic Bench Reference (published in 1994, page 10) and incorporated herein by reference. When included in the present invention, the antimicrobial agent is present at a level of from about 0.01% to about 25%, preferably from about 0.1% to about 10% by weight of the composition.

When used in the axilla, a restriction component may be included in the present invention. Examples of conventional known limiting agents are described in the Cosmetic Bench Reference (published in 1994, page 13) and incorporated herein by reference. When included in the present invention, the limiting agent may be present from about 0.1% to about 25% by weight of the composition.

Skin support

The composition of the present invention also optionally includes a skin support agent. Skin support agents as used herein refer to skin protectants, thickeners and moisturizers.

Skin protectants useful in the present invention are described in the Cosmetic Bench Reference (published in 1994, page 53; and Paper Publication, 21 CFR 347, entitled “Skin Protectant Drug Products for Over-the-Counter Human Use”). Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oatmeal and mixtures thereof. When included in the present invention, the skin protectant contains about 0.1% to about 80%, more preferably about 0.1% to about 30%, most preferably about 0.1% to about 10% by weight of the composition. .

Viscosifiers and humectants useful in the present invention are described in the Cosmetic Bench Reference (published in 1994, pages 27-32 and 46-48) and incorporated herein by reference. Preferred thickeners and moisturizers are tocopherol, tocopheryl acetate, aloe, cooking oil, mineral oil, petrolatum, jojoba oil and mixtures thereof. More preferred are encapsulated or sprayed / freeze dried viscosities. The use of encapsulated or sprayed / freeze-dried viscous agents allows the viscous agent to be released into the powder carrier until they are released through shearing (such as rubbing against underwear or clothing) or through contact with skin moisture. Keep protected at Examples of preferred commercially available spray / freeze dried aloes useful in the present invention are Terra-Dry ^™ freeze dried aloe, Terra-Pure ^™ freeze or spray dried aloe and Terra-Spray ^™ spray dried aloe, all of which are trademarks of Terry Laboratories. When included in the present invention, the viscous / humidifier contains about 0.1% to about 50%, preferably about 0.1% to about 25%, most preferably about 0.1% to about 10% by weight of the composition. do.

Slip Compound

The composition of the present invention may optionally contain a slip compound. The term "slip compound" as used herein refers to a compound having a unique structure that provides enhanced slippery / lubricating characteristics of the powder and / or reduced interskin friction between intertriginous skin regions.

Slip compounds of the present invention include: polyethylene; nylon; Polytetrafluoroethylene; Silica, such as microparticles | fine-particles, an ellipsoid, and a cylindrical shape; Mica, silicone (eg dimethicone) and stearate metal salts (eg zinc stearate); And mixtures thereof. Preferred slip compounds are silica, such as microparticles, ellipsoids and tubular forms. Ellipsoidal silica useful in the present invention is a trade name ZELEC sold by DuPont. Sil. Microparticulate silicas available from KOBO are MSS-500, MSS-500 / 3, MSS-500 / H, MSS-500 / 3H, MSS-500 / N and MSS-500 / 3N. By addition, some of the silica of the present invention is preferably fume silica in order to improve the slip properties and increase the fluidity of the powder. Fumed Silica is Cabot Corporation (trade name Cab-O-Sil ) And Degussa (tradename Aerosil Commercially available).

When included in the composition of the present invention, the slip compound contains from about 0.1% to about 35%, preferably from about 1% to about 10% by weight of the composition.

Binder

The present invention may also optionally include dry or wet binders that help improve the adsorption of powders and active ingredients on the skin. Binders useful in the present invention are described in the Cosmetic Bench Reference (published in 1994, pages 13-14) and incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropyl myristate, magnesium myristate, silicone and mixtures thereof. More preferred binders are zinc stearate, dimethicone and mixtures thereof.

When included in the compositions of the present invention, the binder is at a level of about 0.1% to about 25%, preferably about 1% to about 15% by weight of the composition.

Anti-Pruritic Agent

Conventional known antipruritic agents can be included as compositions of the present invention. Examples of antipruritic agents useful in the present invention are magnesium-L-lactate, hydrocortisone, hydrocortisone acetate and colloidal oatmeal. Antipruritic agents are described in Handbook of Non Prescription Drugs (1993, 10th edition, page 529) and incorporated herein by reference. When included in the compositions of the present invention, the antipruritic agent is present from about 0.1% to about 40% by weight of the composition.

coloring agent

Colorants and dyes may optionally be added to the absorbent compositions for visual appeal and feeling of efficacy. Colorants suitable for use in the present invention are described in the Cosmetic Bench Reference (published in 1994, pages 21-22) and incorporated herein by reference.

Method of Preparation of the Composition

The composition of the present invention is prepared in the following steps: Mixing any of the components in the cyclodextrin, the high efficiency moisture absorbent (if included) and the powder carrier through a commercial mixer such as a V-type blender, a double-conical blender or a ribbon blender. To produce a mixture by mixing until it is uniform; And commercially useful size reduction techniques such as hammer milling, impact milling, ball milling or latex energy milling to produce mixtures of reduced size until the desired particle size distribution is achieved.

Since the composition of the present invention is applied directly to the skin or hair, various applicators are useful for delivering the composition to the occluded skin area to maximize odor control. For example, the composition is preferably deposited on a bottle, canister, spray dosing machine, manual spray dosing device or on a wipe structure that subsequently contacts the skin and delivers the composition to the skin.

Conventional known bottles and canisters are suitable for use in delivering the compositions of the present invention. The bottle and canister preferably comprise a lid with a small hole for convenient administration of the composition of the present invention.

The compositions of the present invention may also be delivered as a solution suspended through a spray dosing or bottle so that when applied or sprayed onto the skin, the solvent immediately dries / volatiles to leave the powder film. Examples of such suspension forms are aerosols, liquid feeder suspensions or silicone suspensions. When included in an aerosol composition, the powder of the present invention is typically present in the range of about 0.1% to about 15% by weight of the composition. Inclusion of powders into aerosols is described in detail in US Pat. No. 4,078,051, published by Pomot et al., March 7, 1978, which is incorporated by reference in its entirety. However, this method is undesirable for use for sensitive areas of the body, such as panty areas or other occluded skin areas, as the irritation of the skin results from propellants commonly used in aerosol containers.

Manual spray dosing devices are preferred for delivering the compositions of the present invention without the use of propellants and as a powder that is not in solution. Spray dosers useful in the present invention are described in detail in US Pat. No. 2,450,205 (Rose, published Sep. 28, 1948) and US Pat. No. 2,840,277 (published June 24, 1958). The full text of the specification is included as a reference.

Any conventionally known wipe structure and / or method of making a wipe structure can be used in the present invention. The wipe consists of a flexible dosage means. The term "flexible dosing means" as used herein includes paper, fabrics, nonwovens, films, foams, sponges, rollers, pads, tissues, cotton balls, and the like. Preferred wipe structures consist of a porous material such as a nonwoven material, a foaming agent, a sponge, or the like, which can keep the composition into the pores of the substrate. Examples of cellulosic nonwovens that are particularly useful and economical in the present invention are described in detail in US Pat. No. 4,191,609 (Trokhan, published March 4, 1980), which is incorporated by reference in its entirety.

Techniques for combining wipe materials with compositions of the present invention are known in the art. Examples of conventional methods of combining a composition of the present invention with a wipe material may include coating, impregnating, dipping, sprinkling or spraying the wipe material with the composition of the present invention. The composition of the present invention is added to the wipe material to a level sufficient to provide the desired malodor control and / or other desired skin effects of the present invention.

Use of Powder Composition

The present invention also encompasses the use of the compositions described herein consisting of applying the compositions described herein to occluded skin in reducing human body odor and excess moisture. The present invention also encompasses the use of the compositions described herein in reducing vaginal odor on the body consisting of applying the compositions described herein to the pelvic zone, extravaginal and / or panty areas. However, the compositions of the present invention should not be inserted into the vagina or vulva.

As used herein, an "effective amount" of a composition of the present invention means an amount sufficient to absorb body odor and / or excess moisture such that body odor is not identified as a human smell and excess moisture is not present.

The composition of the present invention is applied topically directly to the skin or hair. The composition can be delivered by placing the composition into a dispensing means and applying an effective amount by spraying, spraying, shaking, or rubbing the composition onto the desired skin surface. Preferably the dosing means is a preformed wipe consisting of a canister, spray bottle or flexible dosing means.

Instead, the user may deposit the composition of the present invention on a wipe consisting of a self-selected flexible dosage means. To do this, the user simply selects a flexible dosage means such as a towel or puff; The composition of the present invention is applied to a desired site of the body from a suitable container on a selected flexible dosage means. The user may also use his or her hand to apply the composition of the present invention. The user can use the composition of the present invention as much or as little as he / she wants, depending on the intended use of the user and the degree of odor and moisture suppression required.

The following non-limiting examples illustrate the formulations and methods of use of the present invention.

Examples I, II and III

Example I Example II Example III

Component W / W,% W / W,% W / W,%

Corn Starch (dermal Starch) 64.80 52.20-

Micro Starch--54.50

Talc-10.00-

Mica--2.00

Silica (Microparticles) 2.00 3.00-

Silica (Ellipsoid)--2.00

Fume Silica 2.00 1.00 1.00

Zinc Phenolsulfonate 3.00 3.00-

Triclosan 0.20 0.30 0.50

Aluminum Chlorohydrate--5.00

Cyclodextrin 3.00 13.00 6.00

Aloe vera, frozen / spray dried 1.00 0.50 1.00

Polyethylene Powder--5.00

Nylon-12 5.00 5.00 5.00

Zinc Stearate 7.00 3.00 5.00

Tocopheryl Acetate 2.00 2.00-

Tocopheryl Acetate Oil--3.00

(Vitamin E acetate)

Use of Microcapsules-

Mineral oil-2.00-

Dimethicone 10.00 10.00 10.00

Total 100.00 100.00 100.00

Examples I and II may also use antipruritic agents such as colorants and / or magnesium-L-lactate. Example III may also contain zeolites.

Examples IV, V and VI

Example IV Example V Example VI

Component W / W,% W / W,% W / W,%

Corn Starch (dermal Starch)--29.25

Tapioca Starch-54.60-

Oat flour / colloidal oatmeal--16.35

Aluminum Starch Octenyl 30.80--

Succinate (Dry Flo Pure)

Talc 13.60 4.90-

Zeolite 10.00--

Silica (microparticles)-2.50 2.50

Fume Silica-2.00-

Silica (Ellipsoid) 4.00-1.50

Kaolin--8.00

Zinc Phenolsulfonate 7.00--

Zinc oxide-4.00 2.00

Triclosan 0.60 1.00 0.40

Cyclodextrin 10.00 4.00 5.00

Aloe Vera, Gel / Oil 1.00 2.00 2.00

Polyethylene Powder 7.00-4.00

Nylon-12-10.00 4.00

Zinc Stearate 5.00 6.00 10.00

Isopropyl Myristate-4.00-

Tocopheryl Acetate--5.00

Microcapsules--Use

Mineral Oil 5.00--

Dimethicone 6.00 5.00 10.00

Total 100.00 100.00 100.00

Examples V and VI may also contain sodium bicarbonate.

Examples VII, VIII and IX

Example VII Example VIII Example IX

Component W / W,% W / W,% W / W,%

Corn Starch (Slight Starch) 50.80 26.70 23.20

Talc--10.00

Silica (Microparticles) 2.50 10.00 10.00

Fume Silica 0.50 5.00 5.00

Silica (Ellipsoid) 1.50--

Kaolin 14.50--

Zinc Phenolsulfonate 2.00 3.00 3.00

Triclosan 0.20 0.20 0.30

Cyclodextrin 8.00 3.00 3.00

Aloe Vera, Gel / Oil 3.00 0.10 0.50

Magnesium Carbonate-8.00 8.00

Calcium Silicate-20.00 20.00

Polyethylene Powder 5.00--

Nylon-12 2.00 5.00 5.00

Zinc Stearate-7.00 3.00

Isopropyl myristate 2.00--

Tocopheryl Acetate 3.00 2.00 2.00

Enable Use Microcapsules

Mineral oil--2.00

Dimethicone 5.00 10.00 5.00

Total 100.00 100.00 100.00

Examples VII and VIII may also use antipruritic agents such as magnesium-L-lactate. Example IX may also use zeolites and / or colorants.

Example X, XI and XII

Example X Example XI Example XII

Component W / W,% W / W,% W / W,%

US starch 23.40--

Aluminum Starch Octenyl-17.40-

Succinate (Dry Flo Pure)

Tapioca Starch--13.10

Mica 2.00--

Talc--4.90

Silica (Microparticles)--20.00

Fume Silica 5.00 8.00 2.00

Silica (Ellipsoid) 14.50 8.00-

Zinc Phenolsulfonate-7.00-

Zinc Oxide--4.00

Triclosan 0.10 0.60 1.00

Aluminum Chlorohydrate 5.00--

Cyclodextrin 6.00 10.00 4.00

Aloe Vera, Freeze / Spray Dried 1.00--

Aloe vera gel / oil-1.00 2.00

Calcium Carbonate 10.00 3.00 4.00

Magnesium Carbonate-7.00 5.00

Calcium Silicate 10.00 15.00 15.00

Polyethylene Powder 3.00 7.00-

Nylon-12--10.00

Zinc Stearate 7.00 5.00 6.00

Isopropyl myristate--4.00

Tocopheryl Acetate Oil

(Vitamin E Acetate) 3.00--

Mineral Oil-5.00-

Dimethicone 10.00 6.00 5.00

Total 100.00 100.00 100.00

Example X may also use zeolites and / or colorants.

Examples XIII and XIV

Example XIII Example XIV

Component W / W,% W / W,%

Corn Starch (Light Starch) 10.25 8.80

Oatmeal / Colloidal Oatmeal 8.35-

Kaolin-4.00

Silica (Microparticles) 5.00 5.00

Fume Silica 5.00 5.00

Silica (Ellipsoid) 10.00 5.00

Zinc phenolsulfonate-2.00

Zinc Oxide 2.00-

Triclosan 0.40 0.20

Cyclodextrin 5.00 8.00

Aloe Vera, Gel / Oil 2.00 3.00

Calcium Carbonate 5.00-

Magnesium Carbonate 4.00 10.00

Calcium Silicate 10.00 25.00

Polyethylene Powder 4.00 5.00

Nylon-12 4.00 2.00

Zinc Stearate 10.00 7.00

Tocopheryl Acetate 5.00 3.00

Isopropyl myristate-2.00

Use microcapsules

Dimethicone 10.00 5.00

Total 100.00 100.00

Examples XIII and XIV may also contain sodium bicarbonate.

The above embodiment is carried out in the following steps: The cyclodextrin, the high efficiency moisture absorbent, any dry ingredients and the powder carrier are made to be homogeneous in a commercial mixer such as a V-type blender, a double cone blender or a ribbon blender. Preparing a mixture by mixing until mixed; Grinding / grinding techniques such as hammer milling, impact milling, ball milling or latex energy milling to reduce the particle size of the mixture; And any liquid viscous agent, moisturizer and / or skin protectant, is added to the mixture to prepare a second mixture, which is preferably mixed using a spray atomizer for more uniform dispersion. The second mixture is then subjected to a second grinding / grinding step and, if desired, air sorting operations.

Formulations for skin use:

Compositions of the invention, such as those formed from examples, can be loaded onto wipes or deposited into spray devices or canisters. The composition may be applied directly onto the skin or to a flexible dosage means selected by the user for convenient use on the skin.

Manufacture of wipes:

The composition of the invention is coated, sprinkled or sprayed onto the dry, flexible dosage means until the desired coating or thickness of the composition of the invention is achieved on the flexible dosage means.

Preparation of the nebulizer:

The composition is deposited in a selected spray package. The package is sealed for storage until consumer use. To produce a pressurized aerosol spray, the composition is delivered into a suitable container. After injecting propellant material, pressurize and seal the container.

Example XV

Women with urinary incontinence know that the humidity associated with this condition causes vaginal odor and discomfort. Women want to reduce both excess moisture and vaginal odors. After urination, the woman wipes the vaginal outer and pelvic areas with a wipe containing the composition of Example VI. The woman notices less odor after using the wipe. The woman uses the composition of Example XIV instead, and after using the wipe, notices that there is less odor and less moisture.

Example XVI

Women with large breasts notice sweating easily during exercise and experience skin abrasions under the breast. Before and after exercise, the woman applies the composition of Example III via a manual nebulizer bottle. The woman is sprayed with the composition under the breast, using a powder sprayer, and notices a less malodorous and more comfortable feeling. The woman instead uses the composition of Example XIV and notices less malodor and moisture after using the wipe.

Example XVII

Men with severe allergies to cosmetic deodorants and limiters avoid using these products. Because of this excess water accumulation, an uncontrolled and embarrassing body odor occurs. The physician recommends using the mild malodorous and moisture absorbent compositions of Example I or VIII. The man applies the composition systemically through the nebulizer every morning after the shower and does not suffer from an allergic reaction. When using the composition of Example I or VIII, the man notices less malodor. As is necessary for particularly hot, sweaty days, for convenient and individual reuse, the man is active with a wipe of the pouch which also contains the composition of Example VIII.

Example XVIII

Fat women have some large skin folds in their abdomen, where excess moisture often accumulates, causing body odor. Women want to reduce body odor as well as excess moisture. The woman uses the composition of Example IV by spraying the composition from the bottle into the palm of the hand and rubbing the composition into the intertriginous region between the folds as well as other occluded skin areas. The woman notices less odor. The woman uses the composition of Example XI instead and notices less malodor and moisture after using the wipe.

Claims (14)

Deodorizing compositions containing the following and are safe for use on the skin: a. 0.1% to 25% uncomplexed cyclodextrin by weight of the composition; And b. Powder carrier. The composition of claim 1, further comprising a slip compound. Odor and moisture absorption compositions containing the following and are safe for use on the skin: a. 0.1% to 25% uncomplexed cyclodextrin by weight of the composition; b. Powder carrier; And c. 5% to 60% high efficiency moisture absorbent by weight of composition 4. The composition of claim 3 wherein the high efficiency moisture absorbent is selected from the group consisting of silicates, silicas and carbonates. The composition of claim 4 wherein the high efficiency moisture absorbent is selected from the group consisting of calcium silicate, amorphous silica, calcium carbonate, magnesium carbonate and zinc carbonate. The cyclodextrin according to any one of claims 1 to 5, wherein the cyclodextrin is a derivative of beta-cyclodextrin, beta-cyclodextrin, alpha-cyclodextrin, derivative of alpha-cyclodextrin, gamma-cyclodextrin, gamma-cyclodextrin, A composition selected from the group consisting of derivatives and mixtures thereof. The composition according to claim 1, wherein the particle size is from 1 micron to 100 microns, preferably from 1 micron to 60 microns, most preferably from 1 micron to 20 microns. The composition of claim 1, wherein the particle size of the cyclodextrin is from 1 micron to 12 microns, most preferably from 1 micron to 5 microns. The composition according to any one of claims 1 to 8, further comprising an odor inhibitory adjuvant selected from the group consisting of zeolite, activated carbon, sodium bicarbonate, antibacterial and limiting agent. 10. The composition according to any one of claims 1 to 9, further comprising a skin support agent selected from the group consisting of skin protectants, thickeners and moisturizers. A pre-formed wipe composition in which the composition according to any one of claims 1 to 10 is deposited on a wipe consisting of flexible administration means. The composition of any one of claims 1 to 11, which is delivered as a powder by a manual spray dispenser. Use of inhalable compositions for the reduction of body odor and / or vaginal odor, which are used in occluded skin, pelvic area, vulva and / or panty-area: a. 0.1% to 25% uncomplexed cyclodextrin by weight of the composition; And b. Powder carrier Use of odor and moisture absorbent compositions for use in occluded skin, pelvic area, vulva and / or panty-area, for the purpose of reducing body odor and / or vaginal odor and excess moisture: a. 0.1% to 25% uncomplexed cyclodextrin by weight of the composition; And b. 5% to 60% high efficiency moisture absorbent by weight of the composition; And c. Powder carrier.